Tolerability of 1 Hour Infusions of Pegunigalsidase Alfa in Fabry Disease: Data from the F60/BRILLIANCE Trial (SSIEM 2026) - Aug 17, 2026 - Abstract #P-361A; Pres time: Aug 26, 2026; 05:30 PM - 06:30 PM; Location: Hall 4&5; No abstract available
Fabry Disease • Genetic Disorders
|